Page last updated: 2024-11-08

ononin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID442813
CHEMBL ID465980
CHEBI ID7775
SCHEMBL ID240476

Synonyms (54)

Synonym
3-(4-methoxyphenyl)-4-oxo-4h-chromen-7-yl beta-d-glucopyranoside
formononetin glucoside
4'-methoxyisoflavone-7-o-beta-d-glucopyranoside
CHEBI:7775 ,
MEGXP0_000395
ACON1_000463
formononetin 7-o-glucoside
NCGC00169054-01
3-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
formononetin 7-o-beta-glucoside
formononetin-7-o-beta-d-glucopyranoside
formononetin-7-o-glucoside
ononin, >=99.0% (tlc)
BRD-K86699891-001-01-1
smr001397243
MLS002473151
CHEMBL465980
7beta-(glucosyloxy)formonometin
HMS2225H24
S9113
z0z637970u ,
4h-1-benzopyran-4-one, 7-(beta-d-glucopyranosyloxy)-3-(4-methoxyphenyl)-
unii-z0z637970u
bdbm50409313
SCHEMBL240476
ononoside
7-hydroxy-4'-methoxyisoflavone-7-o-.beta.-d-glucoside
7-(.beta.-glucosyloxy)-3-(4-methoxyphenyl)isoflavone
ononin (constituent of astragalus) [dsc]
ononin [mi]
formononetin 7-o-.beta.-d-glucoside
ononin [usp-rs]
formononetin 7-o-.beta.-d-glucopyranoside
formononetin 7-glucoside
CS-3719
3-(4-methoxyphenyl)-4-oxo-4h-chromen-7-yl .beta.-d-glucopyranoside
MGJLSBDCWOSMHL-MIUGBVLSSA-N
HY-N0270
ononin, united states pharmacopeia (usp) reference standard
AS-72370
fomononetin-7-o-glucoside
ononin (usp-rs)
3-(4-methoxyphenyl)-7-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxychromen-4-one
7-hydroxy-4'-methoxyisoflavone-7-o-beta-d-glucoside
formononetin 7-o-beta-d-glucoside
ononin (constituent of astragalus)
7-(beta-glucosyloxy)-3-(4-methoxyphenyl)isoflavone
3-(4-methoxyphenyl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4h-chromen-4-one
AKOS037514760
3-(4-methoxyphenyl)-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
Q7094502
DTXSID70964089
CCG-269009
formononetin 7-o-b-d-glucopyranoside

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The crude methanol extract of Pueraria lobata was investigated by dual high-resolution α-glucosidase inhibition and radical scavenging profiling combined with hyphenated HPLC-HRMS-SPE-NMR."( Dual high-resolution α-glucosidase and radical scavenging profiling combined with HPLC-HRMS-SPE-NMR for identification of minor and major constituents directly from the crude extract of Pueraria lobata.
Jäger, AK; Kongstad, KT; Liu, B; Nyberg, NT; Qinglei, S; Staerk, D, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
4'-methoxyisoflavonesAny methoxyisoflavone which has a methoxy group at the 4-position of the phenyl substituent.
7-hydroxyisoflavones 7-O-beta-D-glucosideA glycosyloxyisoflavone that is any 7-hydroxyisoflavone compound in which the 7-hydroxy group has been converted into its corresponding O-beta-D-glucoside.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
formononetin conjugates interconversion016
superpathway of formononetin derivative biosynthesis234

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
BRCA1Homo sapiens (human)Potency2.81840.89137.722525.1189AID624202
ATAD5 protein, partialHomo sapiens (human)Potency6.51040.004110.890331.5287AID504466; AID504467
P53Homo sapiens (human)Potency6.45470.07319.685831.6228AID504706; AID624305
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency18.35640.00419.984825.9290AID504444
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency39.81070.050127.073689.1251AID588590
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency10.00000.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency10.00000.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency10.00000.15855.287912.5893AID540303
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldehyde dehydrogenase, mitochondrialHomo sapiens (human)IC50 (µMol)6.00000.04003.40799.0000AID34047
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Interleukin-2Homo sapiens (human)Kd0.12000.00001.30375.4700AID1156797
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (44)

Processvia Protein(s)Taxonomy
carbohydrate metabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
alcohol metabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
ethanol catabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
aldehyde catabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
regulation of dopamine biosynthetic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
regulation of serotonin biosynthetic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
positive regulation of immunoglobulin productionInterleukin-2Homo sapiens (human)
positive regulation of plasma cell differentiationInterleukin-2Homo sapiens (human)
negative regulation of B cell apoptotic processInterleukin-2Homo sapiens (human)
positive regulation of B cell proliferationInterleukin-2Homo sapiens (human)
positive regulation of activated T cell proliferationInterleukin-2Homo sapiens (human)
negative regulation of protein phosphorylationInterleukin-2Homo sapiens (human)
adaptive immune responseInterleukin-2Homo sapiens (human)
leukocyte activation involved in immune responseInterleukin-2Homo sapiens (human)
transcription by RNA polymerase IIInterleukin-2Homo sapiens (human)
immune responseInterleukin-2Homo sapiens (human)
cell adhesionInterleukin-2Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationInterleukin-2Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayInterleukin-2Homo sapiens (human)
cell-cell signalingInterleukin-2Homo sapiens (human)
positive regulation of cell population proliferationInterleukin-2Homo sapiens (human)
natural killer cell activationInterleukin-2Homo sapiens (human)
T cell differentiationInterleukin-2Homo sapiens (human)
positive regulation of cell growthInterleukin-2Homo sapiens (human)
positive regulation of type II interferon productionInterleukin-2Homo sapiens (human)
positive regulation of interleukin-17 productionInterleukin-2Homo sapiens (human)
positive regulation of tissue remodelingInterleukin-2Homo sapiens (human)
interleukin-2-mediated signaling pathwayInterleukin-2Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinInterleukin-2Homo sapiens (human)
negative regulation of apoptotic processInterleukin-2Homo sapiens (human)
response to ethanolInterleukin-2Homo sapiens (human)
positive regulation of regulatory T cell differentiationInterleukin-2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterleukin-2Homo sapiens (human)
regulation of T cell homeostatic proliferationInterleukin-2Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesInterleukin-2Homo sapiens (human)
negative regulation of lymphocyte proliferationInterleukin-2Homo sapiens (human)
negative regulation of inflammatory responseInterleukin-2Homo sapiens (human)
positive regulation of inflammatory responseInterleukin-2Homo sapiens (human)
activated T cell proliferationInterleukin-2Homo sapiens (human)
positive regulation of dendritic spine developmentInterleukin-2Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandInterleukin-2Homo sapiens (human)
response to tacrolimusInterleukin-2Homo sapiens (human)
negative regulation of T-helper 17 cell differentiationInterleukin-2Homo sapiens (human)
regulation of CD4-positive, alpha-beta T cell proliferationInterleukin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
aldehyde dehydrogenase (NAD+) activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
aldehyde dehydrogenase [NAD(P)+] activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
phenylacetaldehyde dehydrogenase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
electron transfer activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
nitroglycerin reductase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
NAD bindingAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
carboxylesterase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
cytokine activityInterleukin-2Homo sapiens (human)
interleukin-2 receptor bindingInterleukin-2Homo sapiens (human)
protein bindingInterleukin-2Homo sapiens (human)
growth factor activityInterleukin-2Homo sapiens (human)
kinase activator activityInterleukin-2Homo sapiens (human)
carbohydrate bindingInterleukin-2Homo sapiens (human)
kappa-type opioid receptor bindingInterleukin-2Homo sapiens (human)
glycosphingolipid bindingInterleukin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
mitochondrionAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
mitochondrial matrixAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
extracellular exosomeAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
extracellular spaceInterleukin-2Homo sapiens (human)
extracellular regionInterleukin-2Homo sapiens (human)
extracellular spaceInterleukin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (61)

Assay IDTitleYearJournalArticle
AID1447219Inhibition of alpha glucosidase (unknown origin) using alpha PNPG as substrate preincubated for 15 mins followed by substrate addition measured after 15 mins2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Constituents with potent α-glucosidase inhibitory activity from Pueraria lobata (Willd.) ohwi.
AID334921Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 10000 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID1779095Antiangiogenic activity against VEGF-stimulated HUVEC cells assessed as reduction in number of sprouting tubules at 5 uM measured after 48 hrs by Matrigel assay based microscopic analysis2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID334932Cytotoxicity in human HeLa cells assessed as effect on cell viability at 50 uM after 1 hr
AID1779100Induction of apoptosis in VEGF-stimulated HUVEC cells assessed as increase in Cytochrome c protein expression at 5 uM measured after 48 hrs by DAPI staining based confocal microscopy2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID1156795Retention time of the compound by chromatography2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID1447211Inhibition of alpha glucosidase (unknown origin) using alpha PNPG as substrate at 0.25 mg/mL preincubated for 15 mins followed by substrate addition measured after 15 mins relative to control2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Constituents with potent α-glucosidase inhibitory activity from Pueraria lobata (Willd.) ohwi.
AID334930Cytotoxicity in human HeLa cells assessed as decrease in cell number at 50 uM after 1 hr
AID334928Cytotoxicity against human Raji cells assessed as cell viability at 10 molar ratio
AID1156796Binding affinity to Bcl-xL (unknown origin)2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID334927Cytotoxicity against human Raji cells assessed as cell viability at 100 molar ratio
AID1779093Antiangiogenic activity against VEGF-induced HUVEC cells assessed as reduction in cell migration at 5 uM measured after 48 hrs by Transwell assay2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID1243356Antioxidant activity assessed as ABTS radical scavenging activity after 6 mins2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Isolation and structure elucidation of bioactive compounds from the roots of the Tunisian Ononis angustissima L.
AID458821Inhibition of Spanish flu (A/Bervig_Mission/1/18) neuraminidase by noncompetitive inhibition assay2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis.
AID1779112Effect on HIF-1beta expression in VEGF-stimulated HUVEC cells at 5 uM measured after 48 hrs by western blot analysis2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID334920Inhibition of TPA-stimulated [32P] incorporation into phospholipids in human HeLa cells at 50 uM after 1 hr
AID334925Cytotoxicity against human Raji cells assessed as cell viability at 10000 molar ratio
AID1779105Cytotoxicity against HUVEC cells assessed as reduction in cell vaibility at 5 uM incubated for 48 hrs by MTT assay2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID402462Antimicrobial activity against beta-hemolytic Streptococcus isolate 48 by paper-disk diffusion method1997Journal of natural products, Apr, Volume: 60, Issue:4
Spinonin, a novel glycoside from Ononis spinosa subsp. leiosperma.
AID1779103Downregulation of HIF-1alpha expression in VEGF-stimulated HUVEC cells at 5 uM measured after 48 hrs by western blot analysis2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID1447210Inhibition of alpha glucosidase (unknown origin) using alpha PNPG as substrate at 0.5 mg/mL preincubated for 15 mins followed by substrate addition measured after 15 mins relative to control2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Constituents with potent α-glucosidase inhibitory activity from Pueraria lobata (Willd.) ohwi.
AID1779114Inhibition of ERK1/2 in VEGF-stimulated HUVEC cells assessed as reduction in phosphorylated MEK1/2 level at 5 uM incubated for 48 hrs by immunoblot analysis2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID1779113Inhibition of MEK1/2 in VEGF-stimulated HUVEC cells assessed as reduction in phosphorylated MEK1/2 level at 5 uM incubated for 48 hrs by immunoblot analysis2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID1779096Induction of apoptosis in VEGF-stimulated HUVEC cells at 5 uM measured after 48 hrs by AnnexinV-FITC/PI staining based flow cytometry2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID334923Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 100 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID334924Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 10 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID1779111Downregulation of HIF-1alpha expression in VEGF-stimulated HUVEC cells at 5 uM measured after 48 hrs by DAPI staining based confocal microscopy2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID1447213Inhibition of alpha glucosidase (unknown origin) using alpha PNPG as substrate at 0.0625 mg/mL preincubated for 15 mins followed by substrate addition measured after 15 mins relative to control2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Constituents with potent α-glucosidase inhibitory activity from Pueraria lobata (Willd.) ohwi.
AID1243355Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Isolation and structure elucidation of bioactive compounds from the roots of the Tunisian Ononis angustissima L.
AID1779097Induction of apoptosis in VEGF-stimulated HUVEC cells assessed as mitochondrial membrane potential alteration at 5 uM measured after 48 hrs by JC-1 staining based flow cytometry2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID1779107Induction of apoptosis in VEGF-stimulated HUVEC cells assessed as increase in cleaved caspase-9 protein expression at 5 uM measured after 48 hrs by western blot analysis2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID334922Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 1000 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID1243357Antioxidant activity assessed as reduction of Fe3+ to Fe2+ after 20 mins2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Isolation and structure elucidation of bioactive compounds from the roots of the Tunisian Ononis angustissima L.
AID34047Inhibition of hamster liver aldehyde dehydrogenase ALDH-22001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.
AID334929Inhibition of EBV-early antigen activation in human Raji cells assessed as early antigen activation at 320 nM
AID639826Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate at 15 uM preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry2012Bioorganic & medicinal chemistry, Feb-01, Volume: 20, Issue:3
Construction of an Indonesian herbal constituents database and its use in Random Forest modelling in a search for inhibitors of aldose reductase.
AID1204997Antioxidant activity of the compound assessed as inhibition of ABTS radicals after 20 mins by spectrophotometric analysis2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Dual high-resolution α-glucosidase and radical scavenging profiling combined with HPLC-HRMS-SPE-NMR for identification of minor and major constituents directly from the crude extract of Pueraria lobata.
AID125225Inhibition of hamster liver mitochondrial monoamine oxidase MAO2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.
AID458822Inhibition of Spanish flu (A/Bervig_Mission/1/18) neuraminidase at 200 uM2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis.
AID1875270Inhibition of MMP9 in human U2OS cells at 5 umol/L by peptide microarray-based fluorescence assay2022Journal of natural products, 10-28, Volume: 85, Issue:10
Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
AID1779102Induction of apoptosis in VEGF-stimulated HUVEC cells assessed as increase in cleaved caspase-3 protein expression at 5 uM measured after 48 hrs by western blot analysis2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID1779101Induction of apoptosis in VEGF-stimulated HUVEC cells assessed as increase in Bax/Bcl2 ratio at 5 uM measured after 48 hrs by western blot analysis2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID1156800Anticancer activity against human HepG2 cells assessed as cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID1156797Binding affinity to IL-2 (unknown origin)2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID1779104Inhibition of VEGFR2 expression in VEGF-induced HUVEC cells at 5 uM incubated for 48 hrs by DAPI staining based confocal microscopy2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID334926Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio
AID1447212Inhibition of alpha glucosidase (unknown origin) using alpha PNPG as substrate at 0.125 mg/mL preincubated for 15 mins followed by substrate addition measured after 15 mins relative to control2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Constituents with potent α-glucosidase inhibitory activity from Pueraria lobata (Willd.) ohwi.
AID1779094Antiangiogenic activity against VEGF-induced HUVEC cells assessed as reduction in wound healing at 5 uM measured after 48 hrs by scratch-wound healing assay2021Journal of natural products, 06-25, Volume: 84, Issue:6
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's2 (13.33)29.6817
2010's9 (60.00)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.67 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index42.91 (26.88)
Search Engine Supply Index2.07 (0.95)

This Compound (34.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]